TYRA
Price:
$14.09
Market Cap:
$744.96M
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is...[Read more]
Industry
Biotechnology
IPO Date
2021-09-15
Stock Exchange
NASDAQ
Ticker
TYRA
According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 647.39M. This represents a change of -23.49% compared to the average of 846.15M of the last 4 quarters.
The mean historical Enterprise Value of Tyra Biosciences, Inc. over the last ten years is 617.73M. The current 647.39M Enterprise Value has changed 10.38% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Enterprise Value was at its highest in in the September 2024 quarter at 1.29B. The Enterprise Value was at its lowest in in the September 2021 quarter at -150456187.23.
Average
617.73M
Median
539.94M
Minimum
69.73M
Maximum
1.11B
Discovering the peaks and valleys of Tyra Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 674.37%
Maximum Annual Enterprise Value = 1.11B
Minimum Annual Increase = -75.28%
Minimum Annual Enterprise Value = 69.73M
Year | Enterprise Value | Change |
---|---|---|
2023 | 539.94M | 674.37% |
2022 | 69.73M | -75.28% |
2021 | 282.08M | -74.14% |
2020 | 1.09B | -1.38% |
The current Enterprise Value of Tyra Biosciences, Inc. (TYRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
297.25M
5-year avg
617.73M
10-year avg
617.73M
Tyra Biosciences, Inc.’s Enterprise Value is greater than Connect Biopharma Holdings Limited (-54815984.00), greater than RAPT Therapeutics, Inc. (27.70M), greater than Xilio Therapeutics, Inc. (-2292216.00), greater than Mineralys Therapeutics, Inc. (539.76M), less than Gracell Biotechnologies Inc. (5.66B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Monte Rosa Therapeutics, Inc. (351.25M), greater than Design Therapeutics, Inc. (331.74M), less than Erasca, Inc. (710.66M), greater than Werewolf Therapeutics, Inc. (-17421672.00), greater than Ikena Oncology, Inc. (37.04M), greater than Stoke Therapeutics, Inc. (451.87M), greater than PMV Pharmaceuticals, Inc. (40.53M), less than Pharvaris N.V. (672.18M), greater than Molecular Partners AG (107.67M), greater than Century Therapeutics, Inc. (89.16M), less than Edgewise Therapeutics, Inc. (2.76B), greater than C4 Therapeutics, Inc. (280.63M), greater than Cullinan Oncology, Inc. (614.81M),
Company | Enterprise Value | Market cap |
---|---|---|
-54815984.00 | $55.03M | |
27.70M | $60.48M | |
-2292216.00 | $50.55M | |
539.76M | $637.04M | |
5.66B | $989.87M | |
138.26M | $181.50M | |
351.25M | $433.13M | |
331.74M | $359.54M | |
710.66M | $726.61M | |
-17421672.00 | $68.63M | |
37.04M | $73.83M | |
451.87M | $599.59M | |
40.53M | $76.07M | |
672.18M | $1.02B | |
107.67M | $195.74M | |
89.16M | $87.15M | |
2.76B | $2.80B | |
280.63M | $273.18M | |
614.81M | $714.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tyra Biosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
What is the 3-year average Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
What is the 5-year average Enterprise Value for Tyra Biosciences, Inc. (TYRA)?
How does the current Enterprise Value for Tyra Biosciences, Inc. (TYRA) compare to its historical average?